Jacob Hughes
Stock Analyst at Wells Fargo
(1.45)
# 2,371
Out of 4,415 analysts
14
Total ratings
57.14%
Success rate
7.84%
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $42.46 | +3.63% | 3 | May 17, 2023 | |
| PRGO Perrigo Company | Upgrades: Overweight | $54 | $32.79 | +64.68% | 1 | Sep 6, 2022 | |
| RVNC Revance Therapeutics | Maintains: Equal-Weight | $17 → $24 | $3.95 | +507.59% | 2 | Aug 25, 2022 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $8.12 | +60.10% | 2 | Aug 16, 2022 | |
| MDWD MediWound | Maintains: Overweight | $49 → $56 | $18.84 | +197.24% | 1 | May 18, 2022 | |
| EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $3.89 | +876.86% | 2 | May 4, 2022 | |
| TEVA Teva Pharmaceutical | Maintains: Equal-Weight | n/a | $13.98 | - | 2 | Jul 29, 2021 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | n/a | $7.82 | - | 1 | Mar 23, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $42.46
Upside: +3.63%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $32.79
Upside: +64.68%
Revance Therapeutics
Aug 25, 2022
Maintains: Equal-Weight
Price Target: $17 → $24
Current: $3.95
Upside: +507.59%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $8.12
Upside: +60.10%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $18.84
Upside: +197.24%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $3.89
Upside: +876.86%
Teva Pharmaceutical
Jul 29, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $13.98
Upside: -
Bausch Health Companies
Mar 23, 2020
Maintains: Equal-Weight
Price Target: n/a
Current: $7.82
Upside: -